Many Americans think they pay too much for their prescription drugs, especially those who need life-saving medications for cancer and hepatitis C. Why are drug costs so high in the United States? How can reporters better explain the cost squeeze to their audiences?
These were among the questions that Sarah Emond, M.P.P., executive vice president at the Institute for Clinical and Economic Review (ICER) in Boston and Peter Bach, M.D., director of the Memorial Sloan Kettering’s Center for Health Policy and Outcomes in New York City addressed at the Feb. 15 meeting of AHCJ’s New York chapter. Dan Goldberg of Politico moderated the session. Continue reading
Local pharmacies have limited hours? Turns out that this is way more than an inconvenience. It may also be a factor in hospital readmissions. Patients who can’t easily get their medications from an accessible, nearby – and open! – pharmacy are more likely to end up back in the hospital.
Experts have been exploring possible reasons why so many patients bounce in and out of the hospital, and why it’s been hard to bring down the 30-day readmission rates, even with new financial incentives under the Affordable Care Act. Continue reading
When Baltimore erupted last spring in the wake of the death of a young black man in police custody, the destruction and looting of one neighborhood CVS Pharmacy quickly became a symbol of the chaos.
Now, as the legal proceedings in the case of Freddie Gray continue, a small part of the Maryland city has healed with the reopening of the store on March 6. Continue reading
As the Department of Health and Human Services continues its shift towards an outcomes-based payment model, one small health system is working with its pharmacists to create an innovative disease management initiative to minimize hospital readmissions and improve health status for its most complex – and costly – patients.
The Comprehensive Health Management program developed by Martin Health System in Stuart, Fla., establishes a progressive role for pharmacists to work directly with older, chronically ill patients. Integrating these neighborhood-based professionals into the system’s primary care practices improves management of patients with chronic diseases such as diabetes, obesity, heart and lung disease, according to David Harlow, Pharm.D., assistant vice president for professional services, clinical imaging, clinical laboratory, clinical pharmacy and disease management at Martin. Continue reading
It hasn’t had quite as much impact as some earlier health-related recession trend stories, but the rise in prescription abandonment rates, detailed in this post by Pharmalot’s Ed Silverman, is starting to snag a few headlines.
According to market research agency Wolters Kluwer, the number of prescriptions for brand-name submitted to a pharmacy but never picked up as crossed the 10 percent threshold, with patients now skipping out on twice as many prescriptions as they did before the recession. The number has been on the rise for a while now, as you can see in this Wall Street Journal graph. The agency releases the numbers every six months.
For more on the issue, I recommend the comment section of this related Pharmalot post.